Identification of PSD-95 as a Regulator of Dopamine-Mediated Synaptic and Behavioral Plasticity

Neuron

Volumn 41, Issue 4, 2004, Pages 625-638

  Yao, Wei Dong ^a   Gainetdinov, Raul R ^a   Arbuckle, Margaret I ^b   Sotnikova, Tatyana D ^a   Cyr, Michel ^a   Beaulieu, Jean Martin ^a   Torres, Gonzalo E ^a   Grant, Seth G N ^b,c   Caron, Marc G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DOPAMINE; POSTSYNAPTIC DENSITY PROTEIN 95; PSYCHOSTIMULANT AGENT;

ADDICTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; DOWN REGULATION; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; GENE IDENTIFICATION; GENOME; LEARNING; LONG TERM POTENTIATION; MOLECULAR DYNAMICS; MOUSE; MUTANT; NERVE CELL PLASTICITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REWARD; SUPERSENSITIVITY; SYNAPSE;

EID: 1342312287     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(04)00048-0     Document Type: Article

References (84)

1. Abarca C., Albrecht U., Spanagel R. Cocaine sensitization and reward are under the influence of circadian genes and rhythm. Proc. Natl. Acad. Sci. USA. 99:2002;9026-9030.
2. Amara S.G., Kuhar M.J. Neurotransmitter transporters. recent progress Annu. Rev. Neurosci. 16:1993;73-93.
3. Beinfeld M.C., Connolly K.J., Pierce R.C. Cocaine treatment increases extracellular cholecystokinin (CCK) in the nucleus accumbens shell of awake, freely moving rats, an effect that is enhanced in rats that are behaviorally sensitized to cocaine. J. Neurochem. 81:2002;1021-1027.
4. Beique J.C., Andrade R. PSD-95 regulates synaptic transmission and plasticity in rat cerebral cortex. J. Physiol. 546:2003;859-867.
5. Bekkers J.M., Stevens C.F. Presynaptic mechanism for long-term potentiation in the hippocampus. Nature. 346:1990;724-729.
6. Berke J.D., Hyman S.E. Addiction, dopamine, and the molecular mechanisms of memory. Neuron. 25:2000;515-532.
7. Bibb J.A., Chen J., Taylor J.R., Svenningsson P., Nishi A., Snyder G.L., Yan Z., Sagawa Z.K., Ouimet C.C., Nairn A.C.et al. Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature. 410:2001;376-380.
8. Burt D.R., Creese I., Snyder S.H. Antischizophrenic drugs. chronic treatment elevates dopamine receptor binding in brain Science. 196:1977;326-328.
9. Carlezon W.A. Jr., Thome J., Olson V.G., Lane-Ladd S.B., Brodkin E.S., Hiroi N., Duman R.S., Neve R.L., Nestler E.J. Regulation of cocaine reward by CREB. Science. 282:1998;2272-2275.
10. Carlsson A., Waters N., Holm-Waters S., Tedroff J., Nilsson M., Carlsson M.L. Interactions between monoamines, glutamate, and GABA in schizophrenia. new evidence Annu. Rev. Pharmacol. Toxicol. 41:2001;237-260.
11. Chen C., Tonegawa S. Molecular genetic analysis of synaptic plasticity, activity-dependent neural development, learning, and memory in the mammalian brain. Annu. Rev. Neurosci. 20:1997;157-184.
12. Cho K.O., Hunt C.A., Kennedy M.B. The rat brain postsynaptic density fraction contains a homolog of the Drosophila discs-large tumor suppressor protein. Neuron. 9:1992;929-942.
13. Collins S.L., Kantak K.M. Neuronal nitric oxide synthase inhibition decreases cocaine self-administration behavior in rats. Psychopharmacology (Berl.). 159:2002;361-369.
14. Creese I., Burt D.R., Snyder S.H. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. Science. 197:1977;596-598.
15. D'Aquila P.S., Collu M., Gessa G.L., Serra G. The role of dopamine in the mechanism of action of antidepressant drugs. Eur. J. Pharmacol. 405:2000;365-373.
16. Daunais J.B., McGinty J.F. Acute and chronic cocaine administration differentially alters striatal opioid and nuclear transcription factor mRNAs. Synapse. 18:1994;35-45.
17. El-Husseini A.E., Schnell E., Chetkovich D.M., Nicoll R.A., Bredt D.S. PSD-95 involvement in maturation of excitatory synapses. Science. 290:2000;1364-1368.
18. Fiorentini C., Gardoni F., Spano P., Di Luca M., Missale C. Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors. J. Biol. Chem. 278:2003;20196-20202.
19. Fuhrmann J.C., Kins S., Rostaing P., El Far O., Kirsch J., Sheng M., Triller A., Betz H., Kneussel M. Gephyrin interacts with Dynein light chains 1 and 2, components of motor protein complexes. J. Neurosci. 22:2002;5393-5402.
20. Gainetdinov R.R., Jones S.R., Caron M.G. Functional hyperdopaminergia in dopamine transporter knock-out mice. Biol. Psychiatry. 46:1999;303-311. a.
21. Gainetdinov R.R., Wetsel W.C., Jones S.R., Levin E.D., Jaber M., Caron M.G. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science. 283:1999;397-401. b.
22. Gainetdinov R.R., Sotnikova T.D., Caron M.G. Monoamine transporter pharmacology and mutant mice. Trends Pharmacol. Sci. 23:2002;367-373.
23. Gainetdinov R.R., Bohn L.M., Sotnikova T.D., Cyr M., Laakso A., Macrae A.D., Torres G.E., Kim K.M., Lefkowitz R.J., Caron M.G., Premont R.T. Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice. Neuron. 38:2003;291-303.
24. Garner C.C., Kindler S. Synaptic proteins and the assembly of synaptic junctions. Trends Cell Biol. 6:1996;429-433.
25. Garry E.M., Moss A., Delaney A., O'Neill F., Blakemore J., Bowen J., Husi H., Mitchell R., Grant S.G., Fleetwood-Walker S.M. Neuropathic sensitization of behavioral reflexes and spinal NMDA receptor/CaM kinase II interactions are disrupted in PSD-95 mutant mice. Curr. Biol. 13:2003;321-328.
26. Gerdeman G.L., Partridge J.G., Lupica C.R., Lovinger D.M. It could be habit forming. drugs of abuse and striatal synaptic plasticity Trends Neurosci. 26:2003;184-192.
27. Gholami A., Haeri-Rohani A., Sahraie H., Zarrindast M.R. Nitric oxide mediation of morphine-induced place preference in the nucleus accumbens of rat. Eur. J. Pharmacol. 449:2002;269-277.
28. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;606-612.
29. Grimm J.W., Lu L., Hayashi T., Hope B.T., Su T.P., Shaham Y. Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine. implications for incubation of cocaine craving J. Neurosci. 23:2003;742-747.
30. Hope B.T., Nye H.E., Kelz M.B., Self D.W., Iadarola M.J., Nakabeppu Y., Duman R.S., Nestler E.J. Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron. 13:1994;1235-1244.
31. Husi H., Ward M.A., Choudhary J.S., Blackstock W.P., Grant S.G. Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat. Neurosci. 3:2000;661-669.
32. Jaffrey S.R., Snyder S.H. Pin. an associated protein inhibitor of neuronal nitric oxide synthase Science. 274:1996;774-777.
33. Kandel E.R. Genes, synapses, and long-term memory. J. Cell. Physiol. 173:1997;124-125.
34. Kelz M.B., Chen J., Carlezon W.A. Jr., Whisler K., Gilden L., Beckmann A.M., Steffen C., Zhang Y.J., Marotti L., Self D.W.et al. Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature. 401:1999;272-276.
35. Kim D.S., Szczypka M.S., Palmiter R.D. Dopamine-deficient mice are hypersensitive to dopamine receptor agonists. J. Neurosci. 20:2000;4405-4413.
36. Kim H.S., Lee G., John S.W., Maeda N., Smithies O. Molecular phenotyping for analyzing subtle genetic effects in mice. application to an angiotensinogen gene titration Proc. Natl. Acad. Sci. USA. 99:2002;4602-4607.
37. Komiyama N.H., Watabe A.M., Carlisle H.J., Porter K., Charlesworth P., Monti J., Strathdee D.J., O'Carroll C.M., Martin S.J., Morris R.G.et al. SynGAP regulates ERK/MAPK signaling, synaptic plasticity, and learning in the complex with postsynaptic density 95 and NMDA receptor. J. Neurosci. 22:2002;9721-9732.
38. Koob G.F., Le Moal M. Drug abuse. hedonic homeostatic dysregulation Science. 278:1997;52-58.
39. Laakso A., Mohn A.R., Gainetdinov R.R., Caron M.G. Experimental genetic approaches to addiction. Neuron. 36:2002;213-228.
40. Lee F.J., Xue S., Pei L., Vukusic B., Chery N., Wang Y., Wang Y.T., Niznik H.B., Yu X.M., Liu F. Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor. Cell. 111:2002;219-230.
41. Livingstone M.S., Sziber P.P., Quinn W.G. Loss of calcium/calmodulin responsiveness in adenylate cyclase of rutabaga, a Drosophila learning mutant. Cell. 37:1984;205-215.
42. Malenka R.C., Nicoll R.A. Long-term potentiation - a decade of progress? Science. 285:1999;1870-1874.
43. McClung C.A., Nestler E.J. Regulation of gene expression and cocaine reward by CREB and DeltaFosB. Nat. Neurosci. 6:2003;1208-1215.
44. McGill G.G., Horstmann M., Widlund H.R., Du J., Motyckova G., Nishimura E.K., Lin Y.L., Ramaswamy S., Avery W., Ding H.F.et al. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell. 109:2002;707-718.
45. McNamara F.N., Clifford J.J., Tighe O., Kinsella A., Drago J., Fuchs S., Croke D.T., Waddington J.L. Phenotypic, ethologically based resolution of spontaneous and D(2)-like vs D(1)-like agonist-induced behavioural topography in mice with congenic D(3) dopamine receptor knockout. Synapse. 46:2002;19-31.
46. Migaud M., Charlesworth P., Dempster M., Webster L.C., Watabe A.M., Makhinson M., He Y., Ramsay M.F., Morris R.G., Morrison J.H.et al. Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein. Nature. 396:1998;433-439.
47. Mirnics K., Middleton F.A., Marquez A., Lewis D.A., Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron. 28:2000;53-67.
48. Mohn A.R., Gainetdinov R.R., Caron M.G., Koller B.H. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell. 98:1999;427-436.
49. Montgomery J.M., Madison D.V. State-dependent heterogeneity in synaptic depression between pyramidal cell pairs. Neuron. 33:2002;765-777.
50. Moore M.S., DeZazzo J., Luk A.Y., Tully T., Singh C.M., Heberlein U. Ethanol intoxication in Drosophila. genetic and pharmacological evidence for regulation by the cAMP signaling pathway Cell. 93:1998;997-1007.
51. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2:2001;119-128.
52. Nishioku T., Shimazoe T., Yamamoto Y., Nakanishi H., Watanabe S. Expression of long-term potentiation of the striatum in methamphetamine- sensitized rats. Neurosci. Lett. 268:1999;81-84.
53. O'Brien J.S., Kishimoto Y. Saposin proteins. structure, function, and role in human lysosomal storage disorders FASEB J. 5:1991;301-308.
54. Prast H., Philippu A. Nitric oxide as modulator of neuronal function. Prog. Neurobiol. 64:2001;51-68.
55. Rahman Z., Schwarz J., Gold S.J., Zachariou V., Wein M.N., Choi K.H., Kovoor A., Chen C.K., DiLeone R.J., Schwarz S.C.et al. RGS9 modulates dopamine signaling in the basal ganglia. Neuron. 38:2003;941-952.
56. Robbins T.W., Everitt B.J. Limbic-striatal memory systems and drug addiction. Neurobiol. Learn. Mem. 78:2002;625-636.
57. Robinson T.E., Berridge K.C. The neural basis of drug craving. an incentive-sensitization theory of addiction Brain Res. Brain Res. Rev. 18:1993;247-291.
58. Robinson T.E., Kolb B. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur. J. Neurosci. 11:1999;1598-1604.
59. Rocha B.A., Fumagalli F., Gainetdinov R.R., Jones S.R., Ator R., Giros B., Miller G.W., Caron M.G. Cocaine self-administration in dopamine-transporter knockout mice. Nat. Neurosci. 1:1998;132-137.
60. Roche K.W., Standley S., McCallum J., Dune Ly C., Ehlers M.D., Wenthold R.J. Molecular determinants of NMDA receptor internalization. Nat. Neurosci. 4:2001;794-802.
61. Rubinstein M., Gershanik O., Stefano F.J. Different roles of D-1 and D-2 dopamine receptors involved in locomotor activity of supersensitive mice. Eur. J. Pharmacol. 148:1988;419-426.
62. Sandberg R., Yasuda R., Pankratz D.G., Carter T.A., Del Rio J.A., Wodicka L., Mayford M., Lockhart D.J., Barlow C. Regional and strain-specific gene expression mapping in the adult mouse brain. Proc. Natl. Acad. Sci. USA. 97:2000;11038-11043.
63. Schnell E., Sizemore M., Karimzadegan S., Chen L., Bredt D.S., Nicoll R.A. Direct interactions between PSD-95 and stargazin control synaptic AMPA receptor number. Proc. Natl. Acad. Sci. USA. 99:2002;13902-13907.
64. Schultz W. Getting formal with dopamine and reward. Neuron. 36:2002;241-263.
65. Sheng M., Kim M.J. Postsynaptic signaling and plasticity mechanisms. Science. 298:2002;776-780.
66. Spyraki C., Fibiger H.C. Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine. Eur. J. Pharmacol. 74:1981;195-206.
67. Stein V., House D.R., Bredt D.S., Nicoll R.A. Postsynaptic density-95 mimics and occludes hippocampal long-term potentiation and enhances long-term depression. J. Neurosci. 23:2003;5503-5506.
68. Thomas M.J., Beurrier C., Bonci A., Malenka R.C. Long-term depression in the nucleus accumbens. a neural correlate of behavioral sensitization to cocaine Nat. Neurosci. 4:2001;1217-1223.
69. Tzschentke T.M., Schmidt W.J. Glutamatergic mechanisms in addiction. Mol. Psychiatry. 8:2003;373-382.
70. Ungless M.A., Whistler J.L., Malenka R.C., Bonci A. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature. 411:2001;583-587.
71. Vanderschuren L.J., Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization. a critical review of preclinical studies Psychopharmacology (Berl.). 151:2000;99-120.
72. Wang Y.M., Gainetdinov R.R., Fumagalli F., Xu F., Jones S.R., Bock C.B., Miller G.W., Wightman R.M., Caron M.G. Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron. 19:1997;1285-1296.
73. Wei F., Qiu C.S., Kim S.J., Muglia L., Maas J.W., Pineda V.V., Xu H.M., Chen Z.F., Storm D.R., Muglia L.J., Zhuo M. Genetic elimination of behavioral sensitization in mice lacking calmodulin-stimulated adenylyl cyclases. Neuron. 36:2002;713-726.
74. White F.J., Kalivas P.W. Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend. 51:1998;141-153.
75. White F.J., Hu X.T., Zhang X.F., Wolf M.E. Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. J. Pharmacol. Exp. Ther. 273:1995;445-454.
76. Whitfield C.W., Cziko A.M., Robinson G.E. Gene expression profiles in the brain predict behavior in individual honeybees. Science. 302:2003;296-299.
77. Wise R.A. Brain reward circuitry. insights from unsensed incentives Neuron. 36:2002;229-240.
78. Wise R.A., Leeb K. Psychomotor-stimulant sensitization. a unitary phenomenon? Behav. Pharmacol. 4:1993;339-349.
79. Wolf M.E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54:1998;679-720.
80. Wong S.T., Athos J., Figueroa X.A., Pineda V.V., Schaefer M.L., Chavkin C.C., Muglia L.J., Storm D.R. Calcium-stimulated adenylyl cyclase activity is critical for hippocampus-dependent long-term memory and late phase LTP. Neuron. 23:1999;787-798.
81. Woolverton W.L., Johnson K.M. Neurobiology of cocaine abuse. Trends Pharmacol. Sci. 13:1992;193-200.
82. Xu F., Gainetdinov R.R., Wetsel W.C., Jones S.R., Bohn L.M., Miller G.W., Wang Y.M., Caron M.G. Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat. Neurosci. 3:2000;465-471.
83. Yuferov V., Kroslak T., Laforge K.S., Zhou Y., Ho A., Kreek M.J. Differential gene expression in the rat caudate putamen after "binge" cocaine administration. advantage of triplicate microarray analysis Synapse. 48:2003;157-169.
84. Zhong Y., Wu C.F. Altered synaptic plasticity in Drosophila memory mutants with a defective cyclic AMP cascade. Science. 251:1991;198-201.